These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 26041981)

  • 1. Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration.
    van Dijk G; van Heijningen S; Reijne AC; Nyakas C; van der Zee EA; Eisel UL
    Front Neurosci; 2015; 9():173. PubMed ID: 26041981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Western diet as a trigger of Alzheimer's disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration.
    Więckowska-Gacek A; Mietelska-Porowska A; Wydrych M; Wojda U
    Ageing Res Rev; 2021 Sep; 70():101397. PubMed ID: 34214643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
    Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F
    Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of Alzheimer's disease and aging.
    Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
    Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xuefu Zhuyu decoction ameliorates obesity, hepatic steatosis, neuroinflammation, amyloid deposition and cognition impairment in metabolically stressed APPswe/PS1dE9 mice.
    Yeh CW; Liu HK; Lin LC; Liou KT; Huang YC; Lin CH; Tzeng TT; Shie FS; Tsay HJ; Shiao YJ
    J Ethnopharmacol; 2017 Sep; 209():50-61. PubMed ID: 28743670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural stem cell therapy for neurovascular injury in Alzheimer's disease.
    Boese AC; Hamblin MH; Lee JP
    Exp Neurol; 2020 Feb; 324():113112. PubMed ID: 31730762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice.
    Elahi M; Hasan Z; Motoi Y; Matsumoto SE; Ishiguro K; Hattori N
    J Alzheimers Dis; 2016; 51(4):1209-24. PubMed ID: 26923011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration.
    Cavaleri F
    Med Hypotheses; 2015 May; 84(5):460-9. PubMed ID: 25691377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
    Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
    J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
    Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
    Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8).
    Porquet D; Andrés-Benito P; Griñán-Ferré C; Camins A; Ferrer I; Canudas AM; Del Valle J; Pallàs M
    Age (Dordr); 2015 Feb; 37(1):9747. PubMed ID: 25663420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease.
    Pérez MJ; Quintanilla RA
    PPAR Res; 2015; 2015():957248. PubMed ID: 26587016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases.
    Hurley MJ; Deacon RMJ; Beyer K; Ioannou E; Ibáñez A; Teeling JL; Cogram P
    Pharmacol Ther; 2018 Aug; 188():36-44. PubMed ID: 29514054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.